These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10746349)

  • 1. Chemoprevention of cancer: a controversial and instructive story.
    Vainio H
    Br Med Bull; 1999; 55(3):593-9. PubMed ID: 10746349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoprevention of cancer: lessons to be learned from beta-carotene trials.
    Vainio H
    Toxicol Lett; 2000 Mar; 112-113():513-7. PubMed ID: 10720774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprevention of bladder cancer.
    Kamat AM; Lamm DL
    Urol Clin North Am; 2002 Feb; 29(1):157-68. PubMed ID: 12109342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of beta-carotene in cancer chemoprevention.
    Toma S; Losardo PL; Vincent M; Palumbo R
    Eur J Cancer Prev; 1995 Jun; 4(3):213-24. PubMed ID: 7647689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance.
    Albanes D; Heinonen OP; Taylor PR; Virtamo J; Edwards BK; Rautalahti M; Hartman AM; Palmgren J; Freedman LS; Haapakoski J; Barrett MJ; Pietinen P; Malila N; Tala E; Liippo K; Salomaa ER; Tangrea JA; Teppo L; Askin FB; Taskinen E; Erozan Y; Greenwald P; Huttunen JK
    J Natl Cancer Inst; 1996 Nov; 88(21):1560-70. PubMed ID: 8901854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial.
    Omenn GS; Goodman GE; Thornquist MD; Balmes J; Cullen MR; Glass A; Keogh JP; Meyskens FL; Valanis B; Williams JH; Barnhart S; Cherniack MG; Brodkin CA; Hammar S
    J Natl Cancer Inst; 1996 Nov; 88(21):1550-9. PubMed ID: 8901853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk.
    Kirsh VA; Hayes RB; Mayne ST; Chatterjee N; Subar AF; Dixon LB; Albanes D; Andriole GL; Urban DA; Peters U;
    J Natl Cancer Inst; 2006 Feb; 98(4):245-54. PubMed ID: 16478743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-steroidal anti-inflammatory drugs and chemoprevention of cancer.
    Vainio H; Morgan G
    Ann Chir Gynaecol; 2000; 89(3):173-6. PubMed ID: 11079784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprevention of colorectal cancer.
    Das D; Arber N; Jankowski JA
    Digestion; 2007; 76(1):51-67. PubMed ID: 17947819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs for preventing lung cancer in healthy people.
    Caraballoso M; Sacristan M; Serra C; Bonfill X
    Cochrane Database Syst Rev; 2003; (2):CD002141. PubMed ID: 12804424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention of colorectal cancer: dietary and pharmacologic approaches.
    Garay CA; Engstrom PF
    Oncology (Williston Park); 1999 Jan; 13(1):89-97; discussion 97-100, 105. PubMed ID: 10027203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of supplementation with alpha-tocopherol and beta-carotene on the incidence and mortality of carcinoma of the pancreas in a randomized, controlled trial.
    Rautalahti MT; Virtamo JR; Taylor PR; Heinonen OP; Albanes D; Haukka JK; Edwards BK; Kärkkäinen PA; Stolzenberg-Solomon RZ; Huttunen J
    Cancer; 1999 Jul; 86(1):37-42. PubMed ID: 10391561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up.
    Virtamo J; Pietinen P; Huttunen JK; Korhonen P; Malila N; Virtanen MJ; Albanes D; Taylor PR; Albert P;
    JAMA; 2003 Jul; 290(4):476-85. PubMed ID: 12876090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diet and cancer: the disconnect between epidemiology and randomized clinical trials.
    Meyskens FL; Szabo E
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1366-9. PubMed ID: 15941942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
    Sandler RS
    Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diet and obstructive lung diseases.
    Romieu I; Trenga C
    Epidemiol Rev; 2001; 23(2):268-87. PubMed ID: 12192737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant micronutrients and biomarkers of oxidative stress and inflammation in colorectal adenoma patients: results from a randomized, controlled clinical trial.
    Hopkins MH; Fedirko V; Jones DP; Terry PD; Bostick RM
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):850-8. PubMed ID: 20200432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction.
    Rapola JM; Virtamo J; Ripatti S; Huttunen JK; Albanes D; Taylor PR; Heinonen OP
    Lancet; 1997 Jun; 349(9067):1715-20. PubMed ID: 9193380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of NSAIDs for the chemoprevention of colorectal cancer.
    Herendeen JM; Lindley C
    Ann Pharmacother; 2003 Nov; 37(11):1664-74. PubMed ID: 14565811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular disease and vitamins. Concurrent correction of 'suboptimal' plasma antioxidant levels may, as important part of 'optimal' nutrition, help to prevent early stages of cardiovascular disease and cancer, respectively.
    Gey KF
    Bibl Nutr Dieta; 1995; (52):75-91. PubMed ID: 8779654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.